In this Feb 2020 bioprocessintl.com article (click here), Dan Stanton talks to Dark Horse CEO Anthony Davies about what pattern Catalent’s $315M acquisition of Masthercell might be foreshadowing.
Anthony Davies considers the possibility of a new CMC norm in this BPI article
- February 13, 2020